Investigators concluded, “[P]atients who seek treatment with medical cannabis for anxiety and depression can experience clinically significant improvements.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Authors reported, “[P]eople with PD report that cannabis subjectively improves some PD‐related symptoms, with higher THC products conferring more frequent benefits than higher CBD products.”
The analysis found that nearly two-thirds of the products contained synthetically derived THC, despite many claiming to be ‘all natural.’
Legal states in 2021 collected an estimated 20 percent more in taxes from retail marijuana sales than from the sale of alcohol products.
“Individuals with depression, anxiety, and comorbid depression and anxiety perceive benefits from using cannabis for sleep,” investigators concluded.
Researchers concluded, “The legalization of recreational cannabis in Uruguay was not associated with overall increases in either past-year/past-month cannabis use.”
Investigators failed to identify changes that could be linked to any “increases in clinically meaningful birth indicators associated with adverse child health.”
Democratic Gov. Andy Beshear said that the establishment of the center should not slow down legislative efforts to legalize medical cannabis access.